JPS61293927A - 肝臓疾患予防治療剤 - Google Patents

肝臓疾患予防治療剤

Info

Publication number
JPS61293927A
JPS61293927A JP61141773A JP14177386A JPS61293927A JP S61293927 A JPS61293927 A JP S61293927A JP 61141773 A JP61141773 A JP 61141773A JP 14177386 A JP14177386 A JP 14177386A JP S61293927 A JPS61293927 A JP S61293927A
Authority
JP
Japan
Prior art keywords
liver
remedy
tablets
results
disordered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61141773A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0156050B2 (enrdf_load_stackoverflow
Inventor
Shigemi Fujisaki
藤崎　茂巳
Mitsuaki Mitani
三谷　満昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP61141773A priority Critical patent/JPS61293927A/ja
Publication of JPS61293927A publication Critical patent/JPS61293927A/ja
Publication of JPH0156050B2 publication Critical patent/JPH0156050B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP61141773A 1986-06-18 1986-06-18 肝臓疾患予防治療剤 Granted JPS61293927A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61141773A JPS61293927A (ja) 1986-06-18 1986-06-18 肝臓疾患予防治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61141773A JPS61293927A (ja) 1986-06-18 1986-06-18 肝臓疾患予防治療剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP56125002A Division JPS5826822A (ja) 1981-08-10 1981-08-10 慢性腎炎治療剤

Publications (2)

Publication Number Publication Date
JPS61293927A true JPS61293927A (ja) 1986-12-24
JPH0156050B2 JPH0156050B2 (enrdf_load_stackoverflow) 1989-11-28

Family

ID=15299839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61141773A Granted JPS61293927A (ja) 1986-06-18 1986-06-18 肝臓疾患予防治療剤

Country Status (1)

Country Link
JP (1) JPS61293927A (enrdf_load_stackoverflow)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007509982A (ja) * 2003-10-29 2007-04-19 アルタス ファーマシューティカルズ インコーポレイテッド 血漿コレシストキニン（ｃｃｋ）濃度を制御するための非膵臓プロテアーゼおよび痛みを処置するための非膵臓プロテアーゼ
JP2010511039A (ja) * 2006-11-28 2010-04-08 ドミトリーヴィッチ ジェンキン ドミトリー 組織の細胞外間隙においてデオキシリボ核酸の量が増量することに関連するヒトの病気の治療方法及び該方法を実施するための医薬製剤
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8535663B2 (en) 2003-07-14 2013-09-17 Cls Therapeutics Limited Method for treating delayed-type hypersensitivity
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
US11701410B2 (en) 2015-05-22 2023-07-18 Cls Therapeutics Limited Extracellular DNA as a therapeutic target in neurodegeneration
US11905522B2 (en) 2018-01-16 2024-02-20 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072733B2 (en) 2003-07-14 2015-07-07 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8535663B2 (en) 2003-07-14 2013-09-17 Cls Therapeutics Limited Method for treating delayed-type hypersensitivity
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8796004B2 (en) 2003-07-14 2014-08-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US9845461B2 (en) 2003-07-14 2017-12-19 Cls Therapeutics Limited Method for treating oncological diseases
US9770492B2 (en) 2003-07-14 2017-09-26 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US9463223B2 (en) 2003-07-14 2016-10-11 Cls Therapeutics Limited Method for monitoring development of somatic mosaicism
JP2007509982A (ja) * 2003-10-29 2007-04-19 アルタス ファーマシューティカルズ インコーポレイテッド 血漿コレシストキニン（ｃｃｋ）濃度を制御するための非膵臓プロテアーゼおよび痛みを処置するための非膵臓プロテアーゼ
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
US8871200B2 (en) 2006-11-28 2014-10-28 Cls Therapeutics Limited Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
JP2010511039A (ja) * 2006-11-28 2010-04-08 ドミトリーヴィッチ ジェンキン ドミトリー 組織の細胞外間隙においてデオキシリボ核酸の量が増量することに関連するヒトの病気の治療方法及び該方法を実施するための医薬製剤
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
US11701410B2 (en) 2015-05-22 2023-07-18 Cls Therapeutics Limited Extracellular DNA as a therapeutic target in neurodegeneration
US11905522B2 (en) 2018-01-16 2024-02-20 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Also Published As

Publication number Publication date
JPH0156050B2 (enrdf_load_stackoverflow) 1989-11-28

Similar Documents

Publication Publication Date Title
JPH0133085B2 (enrdf_load_stackoverflow)
Saravu et al. Acute ingestion of copper sulphate: A review on its clinical manifestations and management
JPS61293927A (ja) 肝臓疾患予防治療剤
KR20140017415A (ko) 세린 프로테아제 억제제의 위로의 투여
US20230210782A1 (en) Non-porcine formulations and methods thereof
BARTELS Hyperthyroidism—an evaluation of treatment with antithyroid drugs followed by subtotal thyroidectomy
JPH0462299B2 (enrdf_load_stackoverflow)
JPH01265028A (ja) 特発性血小板減少性紫斑病治療剤
Adikwu et al. Melatonin and alpha lipoic acid restore electrolytes and kidney morphology of lopinavir/ritonavir-treated rats
CN102188699A (zh) 一种治疗动脉粥样硬化的药物组合物及其制备方法和应用
JPS58189122A (ja) 高脂血症予防治療剤
Warner et al. Tolerability of enalapril in congestive heart failure
Maruyama et al. Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy
CN105944078A (zh) 一种用于治疗慢性肾盂肾炎的复方护理剂及其制备方法
JPS59225122A (ja) 悪液質治療改善剤
Rubinstein et al. Icodextrin-induced acute pancreatitis in a peritoneal dialysis patient: a case report and literature review
EP4126015A1 (en) Method for preventing or treating lung infection and lung inflammation
Soisson et al. An unusual cutaneous reaction to anticoagulant therapy
JPS608227A (ja) 抗アレルギ−増強剤
Gancheva et al. A clinical case of pityriasis lichenoides chronica presenting with palpable purpura after streptococcal infection
Kazama et al. The immunohistochemical localization of α2-Heremans–Schmid glycoprotein/fetuin-A (AHSG)
US20230193228A1 (en) Lipase formulations and methods thereof
JPH07507289A (ja) 抗炎症剤
Ochiai et al. Articular and pancreatic involvement in pyoderma gangrenosum associated with myelodysplastic syndrome
JPS62215533A (ja) 膠原病又は関節リウマチの予防治療剤